Stellar Biotechnologies forming Paris-based company in joint venture
Stellar Biotechnologies will form a Paris-based company in a joint venture with Neovacs. The companies announced the partnership May 11. Neovacs, which is based in Paris, will own 70 percent of the new company, called Neostell. Stellar Biotechnologies will own 30 percent. Based in Port Hueneme, Stellar Biotechnologies makes a protein for immunotherapy treatments using Read More →
Dubroff: Tri-Counties on the front lines of clean energy innovation
The region has a lot at stake in the climate talks in Paris. That’s my takeaway as more than 190 nations gather in the French capital to ponder the future of the carbon-based economy. Bending the curve on carbon emissions has attracted a big global constituency – engaging the Pope, multinational companies, communist regimes Read More →









